Elevance Health (ELV) Net Income towards Common Stockholders (2009 - 2026)

Elevance Health (ELV) has 17 years of Net Income towards Common Stockholders data on file, last reported at $1.5 billion in Q2 2026.

• On a quarterly basis, Net Income towards Common Stockholders fell 16.63% year-over-year to $1.5 billion in Q2 2026; TTM through Jun 2026 was $4.9 billion, a 7.52% decrease from a year earlier, with the FY2025 full-year figure at $5.7 billion, down 5.19% from the prior year.
• Net Income towards Common Stockholders for Q2 2026 stood at $1.5 billion, down from $1.8 billion in the prior quarter.
• Over the last five years, Net Income towards Common Stockholders for ELV reached as high as $2.3 billion in Q2 2024 and fell as low as $413.0 million in Q4 2024.
• Historically, Net Income towards Common Stockholders has averaged $1.5 billion across 5 years, with a median of $1.6 billion in 2022.
• Across the five-year window, Net Income towards Common Stockholders slumped 50.3% in 2024 and soared 32.2% in 2025, its largest moves.
• Year by year, Net Income towards Common Stockholders stood at $877.0 million in 2022, then dropped by 5.25% to $831.0 million in 2023, then slumped by 50.3% to $413.0 million in 2024, then surged by 32.2% to $546.0 million in 2025, then soared by 166.3% to $1.5 billion in 2026.
• Per Business Quant data, the three most recent Net Income towards Common Stockholders figures were $1.5 billion in Q2 2026, $1.8 billion in Q1 2026, and $546.0 million in Q4 2025.